
Chinese biopharma stocks rise as US may ease drug licensing restrictions with China
Chinese biopharma stocks surged in Hong Kong after reports that the US Treasury is drafting rules to allow American pharmaceutical companies to continue licensing most drugs from Chinese firms, excluding sensitive biotech related to pathogens. This p...





